ATM expression as a predictive biomarker for first-line treatment outcomes in metastatic CRC
ATM expression levels show differential survival outcomes for mCRC patients in 1L therapy
INDICATION
Colorectal
BIOMARKER
ATM


Kaplan-Meier survival curves comparing rwOS between ATM-low and ATM-high CRC patients in 1L FOLFIRI (N=716) (A) and 1L FOLFOX (N=2,679) (B) pre-treated samples. Shaded areas represent the 95% confidence intervals. Median survival times are specified. Cohort split on median expression level.
Related cases


